Hideo Takeda, n/a

CTO
Physio Mckina Co., Ltd., Japan

Poster(s):

• (W1030-09-52) Development of L-dopa-Loaded Nanofiber for Transbuccal Drug Delivery
  Wednesday, October 23, 2024

  10:30 AM – 11:30 AM MT

• (M1230-03-15) Coamorphous Nanoparticles Produced by Co-precipitation of Two Drugs Based on Liquid-Liquid Phase Separation: Improved Solubility and Membrane Permeability
  Monday, October 21, 2024

  12:30 PM – 1:30 PM MT

• (W1230-11-61) In Situ Monitoring of Dissolution and Crystallization Processes for Active Pharmaceutical Ingredients Using Low Frequency Raman Spectroscopy
  Wednesday, October 23, 2024

  12:30 PM – 1:30 PM MT

• (T1430-05-25) Monitoring the Dissolution Behavior of Dissolving Microneedles by UV-Vis Imaging System
  Tuesday, October 22, 2024

  2:30 PM – 3:30 PM MT

• (M1530-11-65) Investigation of Dissolution and Permeation Properties of Amorphous Drug Particles Dispersed in Wax-Based Formulations
  Monday, October 21, 2024

  3:30 PM – 4:30 PM MT